Menopause Muscle and Joint Pain Is Common: It's Hormonal
Written by Dr. Fiona McCulloch, ND, author of 8 Steps to Reverse Your PCOS and fellow of the American Board of Naturopathic Endocrinology, with 25+ years of clinical focus in hormonal medicine.
Up to 70% of women experience significant stiffness, joint pain, muscle soreness, or ligament issues during menopause and perimenopause. The symptoms are often diffuse: shoulders that feel locked, a lower back that aches without injury, muscles that are stiff first thing in the morning, reduced range of motion that wasn’t there a year ago. These are not random signs of aging. They reflect specific changes in the hormonal environment that supports your connective tissue, fascia, and joints. This page explains the mechanism behind menopause muscle and joint pain: why it happens, what distinguishes it from other causes, and what can be done.
Common experiences include:
- Shoulder stiffness or a reduced ability to raise your arm above your head
- Morning aching or stiffness that wasn’t there before perimenopause
- Muscle soreness or joint pain without a clear injury or cause
- Ligament laxity, with joints that feel less stable or more easily strained
- General stiffness throughout the body, with everything feeling tighter and less flexible
If You've Been Told This Is Just Aging: It Isn't
Many women describe the same experience: joint pain or muscle stiffness that feels disproportionate to their activity level, and a GP visit that ends with “it’s just getting older. Exercise more.” The frustration is not that the advice is wrong (movement does help), but that it leaves the cause unexamined. When stiffness is progressive, when it started around the time periods changed, and when it affects areas like the shoulders, lower back, and ligaments rather than a single injured joint, there is often a specific hormonal explanation that standard care does not assess.
What many women in perimenopause and menopause experience isn’t structural deterioration. It’s functional change in connective tissue and fascia driven by shifting hormones. There is often a great deal that can be done, especially when addressed early.
How Estrogen Loss Affects Joints, Muscles, and the Entire Fascial System
Estrogen supports collagen production and maintains flexibility throughout the fascial system, the network of connective tissue that runs through joints, tendons, ligaments, and soft tissues. When estrogen declines during perimenopause, the entire fascial system becomes stiffer and less resilient. This is why the musculoskeletal symptoms of menopause often feel whole-body rather than localised: it is not one joint wearing out, but the connective tissue environment throughout the body becoming less flexible. Estrogen also supports synovial fluid production, the lubrication inside joints that allows smooth, pain-free movement. As estrogen falls, joints may feel drier, stiffer, and more vulnerable to daily loading.
Progesterone decline contributes to the picture as well. Progesterone has anti-inflammatory properties and is specifically relevant for muscle spasms and headaches, effects that extend beyond its connective tissue role. When progesterone falls alongside estrogen, the body’s inflammatory balance shifts. In clinical practice, addressing progesterone joint pain alongside estrogen loss often means treating both the stiffness and the spasm component of musculoskeletal discomfort.
Sleep disruption in perimenopause adds a third layer. When sleep quality deteriorates, cortisol levels can rise, and elevated cortisol increases pain sensitivity and promotes inflammation. This cortisol-sleep-pain cycle explains why musculoskeletal discomfort often feels worse after a poor night’s sleep. In many cases, cortisol levels rise in menopause due to sleep issues and stress, and this amplifies the muscle and joint pain already driven by estrogen and progesterone decline. The cortisol contribution may be more pronounced in women who also have thyroid conditions or PCOS, where insulin resistance and circadian disruption compound the effect. For more on the cortisol-estrogen relationship, see our page on cortisol and estrogen in perimenopause. Progesterone’s role in sleep quality and pain recovery is covered in our progesterone and sleep page.
Three Common Conditions Often Missed as Menopause-Related
Certain musculoskeletal conditions are significantly more common during perimenopause and menopause. The connection to hormonal changes is frequently overlooked in standard care, meaning many women are treated for the condition without anyone assessing whether hormones are a contributing factor.
Frozen Shoulder (Adhesive Capsulitis)
Frozen shoulder is particularly common in perimenopause and menopause. As estrogen declines, the fascial thickening and reduced flexibility in the shoulder joint can progress to significantly restricted range of motion. Many women receive physiotherapy for frozen shoulder without any hormonal assessment, and often without the improvement they expected. For shoulder pain and stiffness driven by fascial changes, red light therapy can be a useful complementary approach alongside hormonal support.
Carpal Tunnel Syndrome
Carpal tunnel syndrome is more common during perimenopause due to connective tissue changes and fluid retention shifts that affect the carpal tunnel space. It is frequently attributed to repetitive strain or occupational overuse. The hormonal component is rarely investigated.
Plantar Fasciitis
The plantar fascia is connective tissue, and estrogen decline affects its flexibility and ability to recover from daily loading. Heel pain that worsens around the time periods change may have a hormonal component that is not typically considered in standard assessment.
How We Assess Whether Joint Pain Is Hormonally Driven
The primary clinical indicator is timing. If joint pain, stiffness, or reduced range of motion began, or significantly worsened, when periods started changing, that correlation is clinically meaningful. Women in their mid-to-late 40s and early 50s who can draw a line between menstrual cycle changes and the onset of musculoskeletal symptoms have a strong signal for a hormonal driver. Hormone testing can be part of the assessment, but the symptom timing is often the clearest starting point.
| Presentation | Sensation | Primary Locations | Timing Pattern |
|---|---|---|---|
| Musculoskeletal syndrome of menopause | Stiffness, tightening, aching | Shoulders, lower back, ligaments | Often correlates with period changes or perimenopause onset |
| Inflammatory arthritis | Hot, red, swollen joints | Fingers, knees, specific joints | Not necessarily linked to hormonal transition |
| Fibromyalgia | Soft tissue and muscle tenderness | Widespread or trigger-point pattern | Not specifically linked to perimenopause onset |
When the presentation suggests a mechanical injury, herniated disc, or a pattern that doesn’t fit the hormonal picture, referral to the appropriate specialist is part of the clinical process. A hormonal assessment adds a lens that is frequently overlooked in standard care. It does not replace investigation of other potential causes. Not every person who comes in for musculoskeletal pain receives hormone therapy.
If the symptom pattern above resonates, our menopause and perimenopause program in Toronto can provide a full hormonal assessment. Learn about our menopause program.
Treatment Options for Menopause-Related Muscle and Joint Pain
The right approach depends on individual factors: what symptoms are present beyond joint pain, how much they affect quality of life, what has already been tried, and what the patient wants from treatment. Not every patient with musculoskeletal symptoms receives bioidentical hormone therapy. Assessment starts with understanding the full picture. Many women who have been managing with ibuprofen, physiotherapy, or the “wait and see” approach find that a hormonal assessment offers a different angle on symptoms that haven’t responded to conventional management.
Bioidentical Hormone Replacement Therapy (BHRT)
Bioidentical hormones (estrogen and progesterone) address the primary hormonal driver behind musculoskeletal symptoms in menopause. In clinical experience, BHRT is particularly effective when joint pain occurs alongside other perimenopause symptoms such as hot flashes, mood changes, or metabolic shifts, because treatment addresses multiple concerns simultaneously. For patients with a uterus, progesterone is always included alongside estrogen, and progesterone directly supports muscle spasm reduction, extending the benefit beyond connective tissue alone. For women whose primary symptom is musculoskeletal pain without other hormonal symptoms, the decision to use BHRT is a shared one, guided by symptom severity and patient preference.
Nutritional and Botanical Support
For women who prefer a non-hormonal approach, or who want to start conservatively, there are several evidence-informed options. Omega-3 fatty acids support anti-inflammatory pathways. Anti-inflammatory botanicals and adaptogens can help modulate the cortisol and stress response that amplifies pain. Supplements targeting muscle spasm may reduce specific symptoms. Collagen is a helpful supportive nutrient, but it is not the primary driver of improvement for joint pain, an important distinction given how heavily collagen is marketed for this purpose.
Combined Approach
Anti-inflammatory supplements and botanical support can be used alongside BHRT for additional benefit. This combined approach is often chosen by patients with a significant musculoskeletal burden who also want to address other perimenopause symptoms. It is not a more intensive protocol. It is a more comprehensive one, addressing hormonal, inflammatory, and nutritional pathways together.
Our approach at White Lotus Clinic works through each of these pathways based on individual hormone patterns and patient goals. Learn more about our menopause and perimenopause program.
What Assessment Looks Like and When Improvement Typically Begins
The initial consultation reviews your symptom history: when joint pain or stiffness started, whether changes correlate with your menstrual cycle, and what you’ve already tried. Physical examination may be included where relevant. Hormone testing can be discussed if it would clarify the clinical picture. The outcome of the first visit is a clear conversation about what is likely contributing to your symptoms and what options are available, not an immediate treatment prescription.
Musculoskeletal symptoms typically take longer to respond than vasomotor symptoms like hot flashes, which often improve within two to four weeks. Joint pain, stiffness, and ligament flexibility generally show meaningful improvement within three months. Some patients notice reduced discomfort earlier. The improvement is often gradual. In clinical experience, many women who address these symptoms find that within a few months, the stiffness they struggled with becomes a distant memory. When asked about it at follow-up, some say they almost forgot it was there, because it was not something they had experienced before the hormonal transition began. For women interested in rebuilding strength during the hormonal transition, see our page on gaining muscle with hormonal conditions.
Common Questions About Menopause Muscle and Joint Pain
Why do joints and muscles hurt more during perimenopause and menopause?
Estrogen supports collagen production, joint lubrication (synovial fluid), and flexibility throughout the body’s fascial system. When estrogen declines, the entire connective tissue network becomes stiffer and less resilient, producing joint pain, muscle aching, reduced range of motion, and tendon or ligament sensitivity. Progesterone decline removes an additional anti-inflammatory effect. This recognised pattern is called the musculoskeletal syndrome of menopause.
Are bioidentical hormones safe for treating joint pain?
Current evidence distinguishes bioidentical (body-identical) estrogen and progesterone from the synthetic formulations studied in the 2002 Women’s Health Initiative trial. Body-identical hormones have a different risk profile than those older formulations. Safety is assessed individually, with medical history, personal risk factors, family history, and treatment goals reviewed as part of every consultation. The decision to use BHRT is made collaboratively, based on the clinical picture and patient preference, not prescribed by default.
Do I have to take hormones, or are there other options?
Hormone therapy is one option, not a default. Some patients prefer to start with anti-inflammatory supplements, omega-3 fatty acids, and botanical medicines. Others use a combination of nutritional support and BHRT. The right path depends on symptom severity, quality-of-life impact, and patient preference. Many women with other perimenopause symptoms like hot flashes find that BHRT addresses multiple concerns at once, but it is not required for musculoskeletal symptoms alone.
How long does it take for joint pain to improve with treatment?
Musculoskeletal symptoms typically take longer to respond than hot flashes, which often improve within two to four weeks. Joint pain, stiffness, and ligament flexibility generally show meaningful change within three months. Some patients notice reduced discomfort earlier. In clinical experience, the improvement is often gradual. Many women report that when asked about their joint pain months later, they realise it has largely resolved.
What if my pain turns out not to be hormonal?
Assessment always evaluates whether the symptom pattern fits the hormonal picture. Hormonal musculoskeletal symptoms tend to present as stiffness and aching in the shoulders, lower back, and ligaments, distinct from the hot, red, swollen joints of inflammatory arthritis or the soft tissue tenderness of fibromyalgia. If the presentation suggests a mechanical injury, herniated disc, or autoimmune condition, referral to an appropriate specialist is part of the process. A hormonal assessment adds a frequently overlooked lens. It does not replace other medical evaluation.
Clinical Expertise in Hormonal Medicine: Dr. Fiona McCulloch, ND
Dr. Fiona McCulloch has advanced her knowledge in supportive hormone care and has received the Fellow of the American Board of Naturopathic Endocrinology designation (based on the standard for the American Board of Naturopathic Endocrinology, which is the certification branch of the Endocrinology Association of Naturopathic Physicians), representing advanced training specific to hormonal medicine. She is the author of 8 Steps to Reverse Your PCOS, published by New World Library, and served as a peer reviewer for the 2023 International PCOS Guidelines, the same evidence standard used by medical specialists worldwide. With over 25 years of clinical practice at White Lotus Clinic in North York, Toronto, her work focuses on hormonal conditions including the musculoskeletal effects of perimenopause and menopause. This depth of clinical focus matters when symptoms require more than a generic explanation.
- Fellow, American Board of Naturopathic Endocrinology
- Author, 8 Steps to Reverse Your PCOS (New World Library)
- Peer reviewer, 2023 International PCOS Guidelines
- 25+ years clinical practice in hormonal health, Toronto
Many women who address musculoskeletal symptoms early in perimenopause find that within a few months, the stiffness they struggled with (the shoulder that limited their movement, the morning aching that made getting up difficult) becomes a distant memory. When asked about it at follow-up, some say they almost forgot the pain was there. Movement and flexibility return toward what they were before the transition began.
Explore What's Driving Your Symptoms: Book a Consultation
If joint pain, muscle stiffness, or reduced range of motion is affecting your daily life, especially if these symptoms began when your periods started changing, a consultation can help clarify what’s contributing and what options are available. White Lotus Clinic is located in North York, Toronto, serving patients from across the Greater Toronto Area. The first step is a conversation about your symptoms and goals, not a commitment to a specific treatment.
Book a Consultation Learn About Our Menopause and Perimenopause Program
Call us at (416) 730-8218. We’re located in North York, Toronto.
References
- Watt FE. Musculoskeletal pain and menopause. Post Reproductive Health. 2018;24(1):34-43. doi:10.1177/2053369118757537
- Briggs AM, et al. Musculoskeletal health conditions represent a global threat to healthy aging: a report for the 2015 World Health Organization World Report on Ageing and Health. The Gerontologist. 2016;56(Suppl 2):S243-S255. doi:10.1093/geront/gnw002
- Spetz Holm AC, et al. Prevalence of musculoskeletal pain and its association with menopausal status: a Swedish population-based study. Climacteric. 2023;26(2):117-123. doi:10.1080/13697137.2022.2157786
- Hand HJ, et al. Adhesive capsulitis of the shoulder: is there an association with diabetes and menopause? Shoulder & Elbow. 2021;13(5):569-577. doi:10.1177/1758573220967559
- Schumacher M, et al. Progesterone synthesis in the nervous system: implications for myelination and myelin repair. Frontiers in Neuroscience. 2012;6:10. doi:10.3389/fnins.2012.00010
- Goldberg RJ, Katz J. A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain. Pain. 2007;129(1-2):210-223. doi:10.1016/j.pain.2007.01.020